1 Hallpike CS, Cairns H. Observations on the Pathology of Meniere’s Syndrome: (Section of Otology). Proc R Soc Med. 1938;31(11):1317–1336.
2 Yamakawa K. Über die pathologische Veränderungen bei einem Menièrekranken. J Otorhinolaryngol Soc Jpn. 1938;44:2310–2.
3 Merchant SN, Adams JC, Nadol JB, Jr. Pathophysiology of Meniere’s syndrome: are symptoms caused by endolymphatic hydrops? Otol Neurotol. 2005;26(1):74–81.
4 Lopez-Escamez JA, Carey J, Chung WH, et al. Diagnostic criteria for Meniere’s disease. J Vestib Res. 2015;25(1):1–7.
5 Nakashima T, Pyykko I, Arroll MA, et al. Meniere’s disease. Nat Rev Dis Primers. 2016;2:16028.
6 Huppert D, Strupp M, Brandt T. Long-term course of Meniere’s disease revisited. Acta Otolaryngol. 2010;130(6):644–51.
7 Chiarella G, Petrolo C, Cassandro E. The genetics of Meniere’s disease. Appl Clin Genet. 2015;8:9–17.
8 Tyrrell JS, Whinney DJ, Ukoumunne OC, Fleming LE, Osborne NJ. Prevalence, associated factors, and comorbid conditions for Meniere’s disease. Ear Hear. 2014;35(4):e162–169.
9 Yeo NL, White MP, Ronan N, Whinney DJ, Curnow A, Tyrrell J. Stress and Unusual Events Exacerbate Symptoms in Meniere’s Disease: A Longitudinal Study. Otol Neurotol. 2018;39(1):73–81.
10 Foster CA, Breeze RE. Endolymphatic hydrops in Meniere’s disease: cause, consequence, or epiphenomenon? Otol Neurotol. 2013;34(7):1210–1214.
11 Pyykko I, Nakashima T, Yoshida T, Zou J, Naganawa S. Meniere’s disease: a reappraisal supported by a variable latency of symptoms and the MRI visualisation of endolymphatic hydrops. BMJ Open. 2013;3(2).
12 Ferster APO, Cureoglu S, Keskin N, Paparella MM, Isildak H. Secondary Endolymphatic Hydrops. Otol Neurotol. 2017;38(5):774–779.
13 Merchant SN, Nadol JB. Schuknecht’s pathology of the ear. 3rd editon, 2010. PMPH-USA, Ltd.
14 Eckhard AH, Zhu M, O’Malley JT, et al. Inner ear pathologies impair sodium-regulated ion transport in Meniere’s disease. Acta Neuropathol. 2018.
15 Mori N, Miyashita T, Inamoto R, et al. Ion transport its regulation in the endolymphatic sac: suggestions for clinical aspects of Meniere’s disease. Eur Arch Otorhinolaryngol. 2017;274(4):1813–20.
16 Miyashita T, Inamoto R, Fukuda S, et al. Hormonal changes following a low-salt diet in patients with Meniere’s disease. Auris Nasus Larynx. 2017;44(1):52–7.
17 Nadol JB, Jr. Positive Hennebert’s sign in Meniere’s disease. Arch Otolaryngol. 1977;103(9):524–30.
18 Monsanto RD, Pauna HF, Kwon G, et al. A three-dimensional analysis of the endolymph drainage system in Meniere disease. Laryngoscope. 2017;127(5):E170-E175.
19 Maire R, van Melle G. Vestibulo-ocular reflex characteristics in patients with unilateral Meniere’s disease. Otol Neurotol. 2008;29(5):693–698.
20 Brown DJ, Chihara Y, Curthoys IS, Wang Y, Bos M. Changes in cochlear function during acute endolymphatic hydrops development in guinea pigs. Hear Res. 2013;296:96–106.
21 Brown DJ, Chihara Y, Wang Y. Changes in utricular function during artificial endolymph injections in guinea pigs. Hear Res. 2013;304:70–76.
22 Brown DJ, Pastras CJ, Curthoys IS, Southwell CS, Van Roon L. Endolymph movement visualized with light sheet fluorescence microscopy in an acute hydrops model. Hear Res. 2016;339:112–24.
23 Attye A, Eliezer M, Galloux A, et al. Endolymphatic hydrops imaging: Differential diagnosis in patients with Meniere disease symptoms. Diagn Interv Imaging. 2017;98(10):699–706.
24 Barath K, Schuknecht B, Naldi AM, Schrepfer T, Bockisch CJ, Hegemann SC. Detection and grading of endolymphatic hydrops in Meniere disease using MR imaging. AJNR Am J Neuroradiol. 2014;35(7):1387–1392.
25 Gurkov R, Hornibrook J. On the classification of hydropic ear disease (Meniere’s disease). HNO. 2018;66(6):455–63.
26 Nevoux J, Barbara M, Dornhoffer J, Gibson W, Kitahara T, Darrouzet V. International consensus (ICON) on treatment of Meniere’s disease. Eur Ann Otorhinolaryngol Head Neck Dis. 2018;135(1S):S29–S32.
27 Nakayama M, Masuda A, Ando KB, et al. A Pilot Study on the Efficacy of Continuous Positive Airway Pressure on the Manifestations of Meniere’s Disease in Patients with Concomitant Obstructive Sleep Apnea Syndrome. J Clin Sleep Med. 2015;11(10):1101–1107.
28 Tighilet B, Leonard J, Watabe I, Bernard-Demanze L, Lacour M. Betahistine Treatment in a Cat Model of Vestibular Pathology: Pharmacokinetic and Pharmacodynamic Approaches. Front Neurol. 2018;9:431.
29 Bertlich M, Ihler F, Weiss BG, et al. Role of capillary pericytes and precapillary arterioles in the vascular mechanism of betahistine in a guinea pig inner ear model. Life Sci. 2017;187:17–21.
30 Tighilet B, Leonard J, Lacour M. Betahistine dihydrochloride treatment facilitates vestibular compensation in the cat. J Vestib Res. 1995;5(1):53–66.
31 Strupp M, Hupert D, Frenzel C, et al. Long-term prophylactic treatment of attacks of vertigo in Meniere’s disease-comparison of a high with a low dosage of betahistine in an open trial. Acta Otolaryngol. 2008;128(5):520–4.
32 Lezius F, Adrion C, Mansmann U, Jahn K, Strupp M. High-dosage betahistine dihydrochloride between 288 and 480 mg/day in patients with severe Meniere’s disease: a case series. Eur Arch Otorhinolaryngol. 2011;268(8):1237–40.
33 Adrion C, Fischer CS, Wagner J, et al. Efficacy and safety of betahistine treatment in patients with Meniere’s disease: primary results of a long term, multicentre, double blind, randomised, placebo controlled, dose defining trial (BEMED trial). BMJ. 2016;352:h6816.
34 De Ru JA, Heerens WC. Clinical study of tympanostomy tube placement for patients with intractable Meniere’s disease. J Laryngol Otol. 2015;129(7):727.
35 Garduno-Anaya MA, Couthino De Toledo H, Hinojosa-Gonzalez R, Pane-Pianese C, Rios-Castaneda LC. Dexamethasone inner ear perfusion by intratympanic injection in unilateral Meniere’s disease: a two-year prospective, placebo-controlled, double-blind, randomized trial. Otolaryngol Head Neck Surg. 2005;133(2):285–94.
36 Harcourt JP, Lambert A, Wong PY, et al. Long-Term Follow-Up of Intratympanic Methylprednisolone Versus Gentamicin in Patients With Unilateral Meniere’s Disease. Otol Neurotol. 2019;40(4):491–6.
37 Brackmann DE, Shelton C, Arriaga M.A. . Otologic Surgery 2016.
38 Chia SH, Gamst AC, Anderson JP, Harris JP. Intratympanic gentamicin therapy for Meniere’s disease: a meta-analysis. Otol Neurotol. 2004;25(4):544–52.